男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

US EUROPE AFRICA ASIA 中文
Business / Companies

Guilin at forefront in battle against malaria

By Wang Hongyi (China Daily) Updated: 2015-11-09 09:47

Since 2000, global mortality rates among malaria patients have dropped by 47 percent. In Africa, the rate has come down by 54 percent for adults and 58 percent for children.

GPSC has played an important role, along with major global pharmaceutical companies such as Novartis in Switzerland and Sanofi-Aventis in France, in fighting malaria.

The Chinese company was at the forefront in developing the innovative artesunate vaccine, Artsun, the first of its kind, to replace quinine injections. The WHO has compared it to the "gold standard" in the battle against malaria.

Artsun is now registered in more than 30 countries and regions and has a 90 percent market share in treating servere malaria.

During the past three years, GPSC has supplied 23.8 million units of the vaccine globally, saving more than 3.4 million people from the scourge of malaria.

"This is an innovative drug that was developed in China," Guo Guangchang, chairman of Fosun Group, said.

During the past decade, 13 anti-malaria drugs developed by GPSC have been approved by the WHO, including three which are injected and 10 in oral tablets.

The company's products account for 80 percent of China's anti-malaria drug exports.

In the first three quarters of this year, Fosun Pharmaceutical, which includes GPSC, reported revenue of 9 billion yuan ($1.41 billion), a rise of 4.76 percent compared to the same period in 2014.

Further financial details have yet to be released. The company's products include metabolism and digestive system drugs, and vaccines, as well as GPSC's brands.

"At present, Guilin Pharma is building a new manufacturing site which will comply with (international) standards," GPSC said.

"In future, we will have a production capacity of over 15 billion tablets/capsules per year to meet the needs of both domestic and global markets." the company added.

Fosun Pharmaceutical also plans to expand its research and development program by working alongside institutions and other organizations.

"There should be more cooperation with research institutes and organizations," Chen Qiyu, chairman of Fosun Pharmaceutical, said.

"This would help create a much larger platform, allowing us to do a better job globally."

Previous Page 1 2 Next Page

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 万山特区| 金昌市| 平南县| 铅山县| 永泰县| 淮滨县| 陕西省| 邓州市| 望江县| 洛宁县| 苍南县| 隆安县| 韶山市| 东安县| 封开县| 岳西县| 林西县| 孟村| 镇宁| 阳朔县| 汪清县| 南开区| 湘潭市| 吉木乃县| 罗甸县| 旬邑县| 金门县| 巴彦淖尔市| 北辰区| 新野县| 额敏县| 祁阳县| 凤山市| 宜都市| 石柱| 永平县| 福建省| 沙湾县| 乌拉特前旗| 富川| 五河县|